Drug intelligence / Profile preview

Huangqi San (Consun Pharmaceutical Group)

Development stage: Unknown
Lead developer: Guangzhou Consun Pharmaceutical Research
Administration: Oral

Overview

Huangqi San (also known as Huangqi San pellets or SK-01) is an innovative traditional Chinese medicine (TCM) compound formulation developed by Consun Pharmaceutical. Derived from a traditional formula in the Northern Song Dynasty's *Shengji Zonglu* (圣济总录), it is formulated as micropills (pellets) and is being developed for the treatment of diabetic kidney disease (DKD) with qi deficiency syndrome (specifically stage III diabetic nephropathy). The drug is designed to address the shortage of clinical specialty drugs for diabetic kidney disease. It has been evaluated in a Phase II randomized, double-blind, placebo-controlled, dose-parallel clinical trial in China (CTR20202484) to assess its efficacy and safety.

Other names: Huangqi San pelletsHuangqi powder pellets黄芪散微丸黄芪散

Targets

EGFR/ERBB2 (Epidermal growth factor receptor/Receptor tyrosine-protein kinase erbB-2)VEGFA (Vascular endothelial growth factor A)ESR1 (ERα)

Beyond the preview

Go deeper on Huangqi San (Consun Pharmaceutical Group).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huangqi San (Consun Pharmaceutical Group).

Explore the full profile